Recombinant alpha-2a interferon treatment in a child with T-cell leukemia and chronic hepatitis B
✍ Scribed by H. Ören; Ö. Düzovalı; G. Irken
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 175 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Ten patients with hairy cell leukemia (HCL) requiring therapy were treated with recombinant beta-serineinterferon (rIFN-Bser) (90 X lo6 units [Ul subcutaneously three times a week). Eight patients were evaluable for response and nine for toxicity. Five patients (63%) showed normalization of peripher
A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year